HealthcareHUTCHMED pulls regulatory submission for Takeda-partnered cancer drug in ChinaBy Helitra.com·August 31, 2024·1 min read HUTCHMED pulls regulatory submission for Takeda-partnered cancer drug in China Source: SeekingalphaADVERTISEMENT ADVERTISEMENTcancer China drug HUTCHMED pulls regulatory submission Takedapartnered Post navigation Previous storyMediciNova gains after patent win for long COVID therapyNext storyAlnylam falls after full data for heart drug that can rival Pfizer’s
Fitness · HealthcareWomen approaching menopause, how long you need to use contraceptionNovember 18, 2026If you are a woman approaching menopause and have sex with men, you may be wondering what the hormonal changes inside you mean…
Fitness · HealthcareHaven’t Exercised in a While? This Is the Best Time of Day to Go for a WalkNovember 18, 2026If you’re starting a new fitness journey or getting back into exercise after a long break, you’re not alone. Everyone has to begin…
Fitness · Healthcare5 Things Drinking Too Much Alcohol May Be Doing to Your BodyNovember 18, 2026Alcohol and Your Metabolic Health Alcohol and Your Metabolic Health Jaimie Uva, RD, discusses the impact of alcohol on your metabolic health and…